Study of Blood Samples From Newborns With Down Syndrome
What is the purpose of this trial?
RATIONALE: Studying the genes expressed in samples of blood from patients with Down syndrome may help doctors identify biomarkers related to cancer.
PURPOSE: This research study is looking at blood samples from newborns with Down syndrome.
- Up to 1 Year
- Children's Oncology Group
National Cancer Institute (NCI)
- February 2009
- Last Updated:
- August 4, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT00959283